NeuroMetrix, Inc.

    Jurisdiction
    United States
    LEI
    549300WDIIBGIRV0N856
    ISIN
    US6412558800 (NURO)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €2.60M
    Gross margin
    55.4%
    EBIT
    -€7.53M
    EBIT margin
    -289.6%
    Net income
    -€6.70M
    Net margin
    -257.4%

    Statement period: - (published )

    Dividends

    Last dividend amount
    $0.15
    Ex date
    Payment date

    Earnings Calls

    Latest earnings call: February 22, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 26K $116.65K +15K Buy

    Add to watchlist

    Notifications